A PHASE 1B STUDY OF ZN-C5 IN CHINESE SUBJECTS
NCT04852419
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Breast Neoplasms
Interventions
DRUG:
ZN-c5
Sponsor
Zentera Therapeutics HK Limited